Status:
UNKNOWN
Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation
Lead Sponsor:
Yonsei University
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
20+ years
Brief Summary
This study is prospective Cohort study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is patients with atrial fibrillation taking Elxaban (generic drug of apixaban)...
Eligibility Criteria
Inclusion
- patients with atrial fibrillation taking Elxaban (patients with age more than 19)
- Patients who agree with study inclusion
Exclusion
- patients who do not agree with study inclusion
- patients with age less than 19
- Pregnancy, Breastfeeding
Key Trial Info
Start Date :
January 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04125641
Start Date
January 2 2020
End Date
March 1 2024
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology Severance Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, South Korea, 03722